Loading...
GREY logo

Grey Matters Health Inc.CNSX:GREY Stock Report

Market Cap CA$1.8m
Share Price
CA$0.45
My Fair Value
n/a
1Y-47.1%
7D0%
Portfolio Value
​
View

Grey Matters Health Inc.

CNSX:GREY Stock Report

Market Cap: CA$1.8m

Grey Matters Health (GREY) Stock Overview

Operates as a clinical stage pharmaceutical development company in Canada and Australia. More details

GREY fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Makes less than USD$1m in revenue (CA$0)

Does not have a meaningful market cap (CA$2M)

Shareholders have been substantially diluted in the past year

Volatile share price over the past 3 months compared to the Canadian market


GREY Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives
UNCY logo
UNCYFeatured

Looking to be second time lucky with a game-changing new product

Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.
View narrative
Community Contributor
US$21.53FV • 64.4% undervalued intrinsic discount
5419.8%Revenue growth p.a.
6.2k
18
0
126
3mo ago

Grey Matters Health Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Grey Matters Health
Historical stock prices
Current Share PriceCA$0.45
52 Week HighCA$1.00
52 Week LowCA$0.34
Beta0.89
1 Month Change-10.00%
3 Month Change-10.00%
1 Year Change-47.06%
3 Year Change-82.00%
5 Year Change-98.94%
Change since IPO-99.81%

Recent News & Updates

Recent updates

Shareholder Returns

GREYCA PharmaceuticalsCA Market
7D0%11.5%0.3%
1Y-47.1%46.0%36.6%

Return vs Industry: GREY underperformed the Canadian Pharmaceuticals industry which returned 38.9% over the past year.

Return vs Market: GREY underperformed the Canadian Market which returned 33.8% over the past year.

Price Volatility

Is GREY's price volatile compared to industry and market?
GREY volatility
GREY Average Weekly Movement17.6%
Pharmaceuticals Industry Average Movement11.5%
Market Average Movement10.6%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market4.0%

Stable Share Price: GREY's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: GREY's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2015n/aChris Moreauwww.algernonhealth.com

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries.

Grey Matters Health Inc. Fundamentals Summary

How do Grey Matters Health's earnings and revenue compare to its market cap?
GREY fundamental statistics
Market capCA$1.82m
Earnings (TTM)-CA$1.93m
Revenue (TTM)n/a
0.0x
P/S Ratio
-1.3x
P/E Ratio

Is GREY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GREY income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$1.93m
Earnings-CA$1.93m

Last Reported Earnings

Nov 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did GREY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/30 05:29
End of Day Share Price 2026/04/30 00:00
Earnings2025/11/30
Annual Earnings2025/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Grey Matters Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre UddinResearch Capital Corporation